Alcon IQ approved in US

Article

The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.

The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.

The AcrySof Toric was initially introduced in 2005. Its acrylic single-piece design provided good rotational stability in addition to the more accurate prediction of power outcomes the lens made possible. The aspheric optic of the new lens will allow for increased contrast sensitivity, and its thinner profile makes it suitable for micro-coaxial surgical techniques.

Alcon plans to launch the AcrySof IQ Toric at the 2009 meeting of the American Society of Cataract and Refractive Surgeons (ASCRS), which will be held in San Francisco, California from April 3–8.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.